3-(alpha-l-arabinopyranosyl)-1-methyl-1-nitrosourea has been researched along with dacarbazine in 1 studies
| Studies (3-(alpha-l-arabinopyranosyl)-1-methyl-1-nitrosourea) | Trials (3-(alpha-l-arabinopyranosyl)-1-methyl-1-nitrosourea) | Recent Studies (post-2010) (3-(alpha-l-arabinopyranosyl)-1-methyl-1-nitrosourea) | Studies (dacarbazine) | Trials (dacarbazine) | Recent Studies (post-2010) (dacarbazine) |
|---|---|---|---|---|---|
| 6 | 1 | 1 | 7,556 | 1,463 | 3,429 |
| Protein | Taxonomy | 3-(alpha-l-arabinopyranosyl)-1-methyl-1-nitrosourea (IC50) | dacarbazine (IC50) |
|---|---|---|---|
| Matrix metalloproteinase-9 | Homo sapiens (human) | 0.556 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Akimov, MA; Gershanovich, ML | 1 |
1 trial(s) available for 3-(alpha-l-arabinopyranosyl)-1-methyl-1-nitrosourea and dacarbazine
| Article | Year |
|---|---|
[Chemoimmunotherapy with dacarbazine and aranose combined with interferon-alpha in disseminated cutaneous melanoma].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Dacarbazine; Female; Glycosides; Humans; Immunologic Factors; Interferon-alpha; Male; Melanoma; Methylnitrosourea; Middle Aged; Skin Neoplasms; Treatment Outcome | 2004 |